Leidos Stock Continues to Face Pressure Over Uncertainty of Health, Defense Portfolios, RBC Capital Markets Says
Leidos posted a Q1 beat but uncertainty into 2027 over the health and defense portfolios continue to weigh on the stock, RBC Capital Markets said in a Tuesday research report. The health segment...